Delivery Order 75F40120D00032-75F40121F19005
Award Date
9/11/21
Potential Completion Date
3/28/24
Potential Value
$478K
Federal Agency
Food and Drug Administration
Awardee
We Pharma, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Two Step
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price delivery order contract to We Pharma, Inc. doing business as WEP Clinical, a self-certified small disadvantaged business, for the delivery of pharmaceutical drug products. The $182,616.74 award is in support of the FDA's research, regulatory compliance, and emergency response operations, and represents task orders under a larger 5-year, $6 million indefinite delivery contract awarded...
We Pharma, Inc. doing business as WEP Clinical has been awarded a firm fixed price delivery order valued at $2,000,000 by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide pharmaceutical products and services in support of FDA operations. This task order was issued against We Pharma's existing indefinite delivery contract with HHS FDA, valued at $6 million over five years, to supply drug products and emergency delivery services for FDA research and...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business structured as a limited liability company. The contract, valued at $199,736.69, is for the procurement of drug products to support the FDA's research, regulatory, and emergency response activities. The contract is designated as a total small business...
We Pharma, Inc. doing business as WEP Clinical has been awarded a firm fixed price delivery order valued at one hundred thousand dollars from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide currently marketed drug products for FDA research studies. This order was issued against the company's existing five-year, nine and a half million dollar contract awarded in 2020 by HHS FDA to supply drug products for internal research in support of the...
This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to We Pharma, Inc., doing business as WEP Clinical. The contract, valued at $197,000.00, is for the procurement of pharmaceutical drug products to support the FDA's Center for Drug Evaluation and Research (CDER) research and regulatory activities. WEP Clinical, a self-certified small disadvantaged business, specializes...
<p>The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $409,719 firm fixed price delivery order contract to We Pharma, Inc., doing business as WEP Clinical, for Pharmaceutical Drug Product Orders. The contract has a period of performance starting on July 31, 2023 through August 6, 2024 and will be performed in Silver Spring, Maryland.</p>
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to We Pharma, Inc. doing business as WEP Clinical, a small disadvantaged business. The contract has a potential value of $365,000.00 and is for the delivery of physicochemical products in support of FDA research, regulatory compliance, and emergency response operations. The contract was awarded on June 29, 2018 with a completion date of July 15, 2023....
This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing...
This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...